Fundraising Fox
Truvian
San Diego, US · Founded 2015 · 105 employees on LinkedIn · 8 known investors
Find your way into Truvian
Sign up to see every warm intro you have to Truvian
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Truvian team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Truvian builds an on-site blood diagnostics platform that combines clinical chemistry, immunoassay, and hematology testing in a single compact instrument. It targets routine blood testing for consumers as an alternative to traditional off-site labs, pursuing a staged FDA clearance strategy for its assays.
Also known as Truvian Health · Truvian Sciences
Founders & leadership
Truvian was founded in 2015 by Dena Marrinucci.
Investors · 8
How we know: the company's own site · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: GreatPoint Ventures's portfolio page · the company's own site · the VCSheet dataset · Not right? Tell us
How we know: Wittington Ventures's portfolio page · the company's own site · Not right? Tell us
How we know: the company's own site · Not right? Tell us
How we know: Embark Ventures's portfolio page · Not right? Tell us
How we know: Medical Excellence Capital's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
Company profile
researched Aug 2026Truvian (Truvian Health) develops TruVerus, a compact benchtop diagnostics platform intended to deliver comprehensive blood testing at the point of care rather than through an off-site laboratory. The system integrates three technologies — clinical chemistry, immunoassay and hematology — into a single automated workflow that runs from one blood sample and returns results in minutes, allowing clinicians to review findings and act while the patient is still present.
The company describes TruVerus as FDA-cleared, with 26 FDA-cleared assays covering commonly ordered tests in preventive care and chronic disease management, including kidney health, liver health, cardiovascular biomarkers, diabetes and glycemic control, metabolic health, and complete blood count. The platform is positioned as expandable, with a test menu designed to grow over time. Stated product attributes include full automation, a compact footprint, a single collection tube for all tests, ambient-stable reagent kits and simple operation.
Business model
Truvian supplies an instrument-plus-consumables diagnostics platform (TruVerus analyzer with ambient-stable assay kits) to care providers and partners, engaging prospects through product demonstrations and partnership arrangements.
▸Full profile — market position, technology, go-to-market, geography
Market position
Positions its onsite platform against traditional laboratory testing, contrasting a separate blood-draw appointment and multi-day turnaround with testing during the patient encounter and immediate action on results.
Consolidation of three testing modalities on one compact instrument, a single sample and workflow for all tests, ambient-stable kits, minutes-long turnaround, and a set of 26 FDA-cleared assays.
Technology
A fully automated benchtop analyzer that combines clinical chemistry, immunoassay and hematology in one workflow, processing a single blood tube with ambient-stable assay kits and producing results in minutes.
Go-to-market
Direct engagement via demo scheduling and partnership inquiries on its website, plus a waitlist for product news, launch updates and early access, targeting health system, retail/pharmacy and clinical research channels.
Health systems seeking to expand diagnostic access, retail and pharmacy settings building new care delivery models, and clinical research organizations using blood testing for screening and enrollment.
Geography
Headquartered in San Diego, United States, with FDA clearance framing a U.S. regulatory focus.
Compiled by commissioned research from 1 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Founder mafia
2 people who came through Truvian went on to found or lead other companies.
Related companies · 1
Companies working in the same space as Truvian.
In the news
▸Research sources · 1
primary sources listed
- Truviantruvianhealth.com · web
1 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Truvian do?
- Truvian makes TruVerus, a benchtop blood-testing platform combining chemistry, immunoassay and hematology at the point of care.
- Who founded Truvian?
- Truvian was founded by Dena Marrinucci in 2015.
- Who are Truvian's investors?
- Truvian's investors include Dns Capital, GreatPoint Ventures, Wittington Ventures, Domain Associates, Embark Ventures, Medical Excellence Capital, XB Ventures, OS Fund.
- Where is Truvian headquartered?
- Truvian is headquartered in San Diego, US.